FLT3 ligand in acute myeloid leukemia: a simple test with deep implications

Peterlin, Pierre, Chevallier, Patrice, Knapper, Steven ORCID: https://orcid.org/0000-0002-6405-4441 and Collin, Matthew 2021. FLT3 ligand in acute myeloid leukemia: a simple test with deep implications. Leukemia & Lymphoma 62 (2) , pp. 264-270. 10.1080/10428194.2020.1834091

PDF - Accepted Post-Print Version Download (298kB)

Abstract

In contrast to Fms-like tyrosine kinase 3 (FLT3), the influence of FLT3 ligand (FLT3L) on acute myeloid leukemia (AML) biology and disease prognosis has been poorly described. Here we provide an overview of the role played by FLT3L in AML. While being a cytokine implicated in the regulation of hematopoiesis, both in normal situation and after intensive chemotherapy, FLT3L has also a role in enhancing proliferation, inhibiting apoptosis and conferring resistance to FLT3 inhibitors in AML. Moreover, recent independent data show how its measurement may be helpful in the disease management. Indeed, FLT3L could provide a low cost, rapid and noninvasive assessment of chemosensitivity and blast clearance that has robust prognostic significance for patients with AML.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Publisher:	Taylor & Francis
ISSN:	1042-8194
Date of First Compliant Deposit:	16 November 2020
Date of Acceptance:	3 October 2020
Last Modified:	03 Dec 2024 08:30
URI:	https://orca.cardiff.ac.uk/id/eprint/136396

Citation Data

Cited 2 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item